BR112019000291A2 - processos inovadores para a preparação de estimuladores de guanilato ciclase solúvel - Google Patents

processos inovadores para a preparação de estimuladores de guanilato ciclase solúvel

Info

Publication number
BR112019000291A2
BR112019000291A2 BR112019000291A BR112019000291A BR112019000291A2 BR 112019000291 A2 BR112019000291 A2 BR 112019000291A2 BR 112019000291 A BR112019000291 A BR 112019000291A BR 112019000291 A BR112019000291 A BR 112019000291A BR 112019000291 A2 BR112019000291 A2 BR 112019000291A2
Authority
BR
Brazil
Prior art keywords
preparation
enhancers
guanylate cyclase
soluble guanylate
processes
Prior art date
Application number
BR112019000291A
Other languages
English (en)
Inventor
Vishnu Vardhan Reddy Karnati
Robert C Livingston
Song Xue
Original Assignee
Ironwood Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ironwood Pharmaceuticals Inc filed Critical Ironwood Pharmaceuticals Inc
Publication of BR112019000291A2 publication Critical patent/BR112019000291A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

a presente invenção se refere a processos inovadores para a preparação de compostos úteis como estimuladores de guanilato ciclase solúvel (sgc). esses processos são passíveis de preparação em larga escala e produzem 3-(2-pirimidinil)pirazóis estáveis de fórmula i, incluindo o composto i, com alta pureza e altos rendimentos. a presente invenção tem a vantagem adicional de condições de reação facilitadas, sendo passível de expansão para fabricação em larga escala. a descrição também fornece novos intermediários úteis na preparação dos ditos compostos.
BR112019000291A 2016-07-07 2017-07-06 processos inovadores para a preparação de estimuladores de guanilato ciclase solúvel BR112019000291A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201662359453P 2016-07-07 2016-07-07
PCT/US2017/040810 WO2018009597A1 (en) 2016-07-07 2017-07-06 Novel processes for preparation of soluble guanylate cyclase stimulators

Publications (1)

Publication Number Publication Date
BR112019000291A2 true BR112019000291A2 (pt) 2019-04-16

Family

ID=59416789

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112019000291A BR112019000291A2 (pt) 2016-07-07 2017-07-06 processos inovadores para a preparação de estimuladores de guanilato ciclase solúvel

Country Status (16)

Country Link
US (3) US11319308B2 (pt)
EP (2) EP4249488A3 (pt)
JP (1) JP7112384B2 (pt)
KR (1) KR102487872B1 (pt)
CN (1) CN109563077A (pt)
AU (1) AU2017291827B2 (pt)
BR (1) BR112019000291A2 (pt)
CA (1) CA3029375A1 (pt)
CL (2) CL2019000016A1 (pt)
EA (1) EA201990237A1 (pt)
ES (1) ES2963563T3 (pt)
IL (1) IL263995B (pt)
MA (1) MA45603A (pt)
MX (2) MX2019000105A (pt)
SG (1) SG11201900096QA (pt)
WO (1) WO2018009597A1 (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG10202100168XA (en) * 2016-07-07 2021-02-25 Cyclerion Therapeutics Inc Novel processes for preparation of soluble guanylate cyclase stimulators
MA45603A (fr) 2016-07-07 2019-05-15 Ironwood Pharmaceuticals Inc Nouveaux procédés de préparation de stimulateurs de la guanylate cyclase soluble
SG11202006311SA (en) 2018-01-10 2020-07-29 Cyclerion Therapeutics Inc Novel processes and intermediates for the preparation of soluble guanylate cyclase stimulators
WO2019161534A1 (en) * 2018-02-22 2019-08-29 Ironwood Pharmaceuticals, Inc. Novel processes and intermediates for preparation of soluble guanylate cyclase stimulators

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8969349B2 (en) 2010-05-26 2015-03-03 Sunovion Pharmaceuticals Inc. Substituted quinoxalines and quinoxalinones as PDE-10 inhibitors
WO2012003405A1 (en) 2010-06-30 2012-01-05 Ironwood Pharmaceuticals, Inc. Sgc stimulators
EP2797915B1 (en) * 2011-12-27 2016-07-13 Ironwood Pharmaceuticals, Inc. 2-benzyl-3-(oxazole/thiazole)-5-(pyrimidin-2-yl)-1(H)-pyrazole derivatives as stimulators of the soluble guanylate cyclase (sGC) for the treatment of e.g. hypertension or heart failure
EP2897953B8 (en) * 2012-09-19 2019-06-26 Cyclerion Therapeutics, Inc. Sgc stimulators
SI3660013T1 (sl) * 2013-03-15 2022-05-31 Cyclerion Therapeutics, Inc. SGC stimulatorji
EP3092231B1 (en) 2013-12-11 2018-06-27 Ironwood Pharmaceuticals, Inc. Sgc stimulators
EP3194382B1 (en) * 2014-09-17 2021-09-08 Cyclerion Therapeutics, Inc. Pyrazole derivatives as sgc stimulators
JP2017527604A (ja) * 2014-09-17 2017-09-21 アイアンウッド ファーマシューティカルズ インコーポレイテッド ｓＧＣ刺激剤
EP3194395B1 (en) * 2014-09-17 2019-12-04 Cyclerion Therapeutics, Inc. Sgc stimulators
WO2016044445A2 (en) * 2014-09-17 2016-03-24 Ironwood Pharmaceuticals, Inc. sGC STIMULATORS
EA201891315A1 (ru) 2015-11-30 2018-12-28 Айронвуд Фармасьютикалз, Инк. Твердые дисперсии, содержащие стимулятор sgc
EP3481820B1 (en) 2016-07-07 2023-10-18 Cyclerion Therapeutics, Inc. Solid forms of an sgc stimulator
MA45603A (fr) 2016-07-07 2019-05-15 Ironwood Pharmaceuticals Inc Nouveaux procédés de préparation de stimulateurs de la guanylate cyclase soluble
SG10202100168XA (en) * 2016-07-07 2021-02-25 Cyclerion Therapeutics Inc Novel processes for preparation of soluble guanylate cyclase stimulators
CA3086207A1 (en) * 2017-12-19 2019-06-27 Cyclerion Therapeutics, Inc. Sgc stimulators
SG11202006311SA (en) * 2018-01-10 2020-07-29 Cyclerion Therapeutics Inc Novel processes and intermediates for the preparation of soluble guanylate cyclase stimulators

Also Published As

Publication number Publication date
US20220227748A1 (en) 2022-07-21
EP3481818B1 (en) 2023-09-06
WO2018009597A1 (en) 2018-01-11
EP4249488A2 (en) 2023-09-27
EA201990237A1 (ru) 2019-08-30
EP4249488A3 (en) 2023-12-20
EP3481818C0 (en) 2023-09-06
SG11201900096QA (en) 2019-02-27
US11773089B2 (en) 2023-10-03
MA45603A (fr) 2019-05-15
CN109563077A (zh) 2019-04-02
KR20190025986A (ko) 2019-03-12
CL2023000228A1 (es) 2023-09-29
CL2019000016A1 (es) 2019-05-03
EP3481818A1 (en) 2019-05-15
US20240059684A1 (en) 2024-02-22
ES2963563T3 (es) 2024-03-27
JP2019525913A (ja) 2019-09-12
MX2019000105A (es) 2019-04-22
KR102487872B1 (ko) 2023-01-12
IL263995A (en) 2019-02-28
IL263995B (en) 2021-02-28
US20210323951A1 (en) 2021-10-21
CA3029375A1 (en) 2018-01-11
MX2022001495A (es) 2022-03-11
AU2017291827B2 (en) 2021-10-21
US11319308B2 (en) 2022-05-03
AU2017291827A1 (en) 2019-02-07
JP7112384B2 (ja) 2022-08-03

Similar Documents

Publication Publication Date Title
BR112019000291A2 (pt) processos inovadores para a preparação de estimuladores de guanilato ciclase solúvel
MY172391A (en) Processes for preparing dihydropyrimidine derivatives and intermediates thereof
NZ701947A (en) Processes to produce certain 2-(pyridine-3-yl)thiazoles
AR118647A1 (es) Proceso de preparación de 2-(3,5-diclorofenil)-6-benzoxazolcarboxilato de 1-deoxi-1-metilamino-d-glucitol
BR112022006052A2 (pt) Processo para a preparação de protioconazol
BR112019000292A2 (pt) processos inovadores para a preparação de estimuladores de guanilato ciclase solúvel
UA111868C2 (uk) Спосіб одержання естерів (5-фтор-2-метил-3-хінолін-2-ілметиліндол-1-іл)-оцтової кислоти
MX2018014130A (es) Procedimiento e intermedios para la 6,7-alfa-epoxidacion de 4,6-dienos esteroideos.
BR112018014534A2 (pt) método e intermediário para a preparação de tulatromicina
CL2022000907A1 (es) Procesos de preparación de un compuesto de fórmula ib, ic o id; y compuestos intermediarios para fabricar un compuesto de fórmula ib, ic o id (div. sol. 202001814).
BR112012013582A2 (pt) processo para síntese de intermediários úteis para a produção de compostos de indazol e azaindazol substituídos
BR112017017066A2 (pt) método de preparação para praziquantel e compostos intermediários do mesmo
CU20190035A7 (es) Derivados sustituidos de 6-(1h-pirazol-1-il)pirimidin-4-amina
EA202191158A1 (ru) Новый способ получения n,n'-бис[2-(1н-имидазол-4-ил)этил]малонамида
MX2021002896A (es) Proceso para preparar 1-(3,5-diclorofenil)-2,2,2-trifluoroetanona y sus derivados.
MX2023004650A (es) Un procedimiento para la preparacion de clorantraniliprol.
BR112023000029A2 (pt) Método de preparação do composto de fenilisoxazolina
BR112012019620A2 (pt) Processo para preparar voriconazol usando novos intermediários
EA202091664A1 (ru) Новые способы и промежуточные соединения для получения стимуляторов растворимой гуанилатциклазы
NZ598129A (en) Process for the preparation of cathepsin s inhibitors
MX2017009839A (es) Proceso para la produccion de derivados de imidazolo condensados.
BR112021020407A2 (pt) Processo para preparação de intermediários para as sínteses de derivados de vitamina a de polienos por ciclização
IN2014KO00147A (pt)
PL400932A1 (pl) Nowe pochodne pirolu i sposób ich otrzymywania
UA110455C2 (en) METHOD FOR SPIRO-λ6-IZOTIAZOLIDYN-1,1,4-TRION

Legal Events

Date Code Title Description
B25A Requested transfer of rights approved

Owner name: CYCLERION THERAPEUTICS, INC. (US)

B350 Update of information on the portal [chapter 15.35 patent gazette]
B06W Patent application suspended after preliminary examination (for patents with searches from other patent authorities) chapter 6.23 patent gazette]